Skip to Main Content

Author Details

Taha Y Taha
Gladstone Institutes
2015
31
9
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36798416Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6.bioRxiv2023
37651466A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo.PLoS Pathog2023
37938000Hepatitis C virus infects and perturbs liver stem cells.mBio2023
37869789Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination.Emerg Microbes Infect2023
37085489Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6.Nat Commun2023
36986317Design and Optimization of a <i>Monkeypox virus</i> Specific Serological Assay.Pathogens2023
37365775Does primary urethral realignment improve the outcome of pediatric pelvic fracture urethral injury? A randomized controlled trial.Int J Urol2023
37131711A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis <i>in vivo</i>.bioRxiv2023
36827975SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants.Stem Cell Reports2023
35044035A randomised trial comparing transurethral to percutaneous cystolithotripsy in boys.BJU Int2022
35839775Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2.Cell Rep2022
35579965Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccination.JCI Insight2022
35858386Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.Proc Natl Acad Sci U S A2022
35982664NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids.bioRxiv2022
35912856Taking cues from convalescence to improve vaccines against hepatitis C virus.J Clin Invest2022
33361417Relative DNA Methylation and Demethylation Efficiencies during Postnatal Liver Development Regulate Hepatitis B Virus Biosynthesis.J Virol2021
33758899Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation.medRxiv2021
34816261Viral E Protein Neutralizes BET Protein-Mediated Post-Entry Antagonism of SARS-CoV-2.bioRxiv2021
33991487Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.Cell2021
32822428Modulation of hepatitis B virus pregenomic RNA stability and splicing by histone deacetylase 5 enhances viral biosynthesis.PLoS Pathog2020
31741333The Regulation of HBV Transcription and Replication.Adv Exp Med Biol2020
30921497Structurally Diverse Histone Deacetylase Photoreactive Probes: Design, Synthesis, and Photolabeling Studies in Live Cells and Tissue.ChemMedChem2019
31531211Correction to Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinoline-Based Histone Deacetylase 8 Selective Inhibitors.ACS Med Chem Lett2019
29682593Histone deacetylase inhibitor-based chromatin precipitation for identification of targeted genomic loci.J Biol Methods2018
29843132Experience of a Tertiary-Level Urology Center in the Clinical Urological Events of Rare and Very Rare Incidence. III. Psychourological Events: 1. Psychic Anuria.Urol Int2018
28835796Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinoline-Based Histone Deacetylase 8 Selective Inhibitors.ACS Med Chem Lett2017
28943357Divergent JNK Phosphorylation of HDAC3 in Triple-Negative Breast Cancer Cells Determines HDAC Inhibitor Binding and Selectivity.Cell Chem Biol2017
29080240Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine-based Histone Deacetylase Inhibitors.ChemMedChem2017
29045501Scaffold dependent histone deacetylase (HDAC) inhibitor induced re-equilibration of the subcellular localization and post-translational modification state of class I HDACs.PLoS One2017
26366859Correction: New Operational Matrices for Solving Fractional Differential Equations on the Half-Line.PLoS One2015
26517833Correction: New Operational Matrices for Solving Fractional Differential Equations on the Half-Line.PLoS One2015
  • 1 - 31 of 31

Recommended Authors

Washington University School of Medicine in St. Louis
Career Start Year 2015
Number of shared co-authors 1
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 2014
Number of shared co-authors 0
University of California los angeles
Career Start Year 2014
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 2
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai, Duke-NUS Medical School
Career Start Year 2012
Number of shared co-authors 1
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 4
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2010
Number of shared co-authors 21
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 2
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 3
J. David Gladstone Institutes
Career Start Year 2009
Number of shared co-authors 8
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 1
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 7
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 0
Johns Hopkins School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 0
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 1
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 1
University of California davis
Career Start Year 2002
Number of shared co-authors 9
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 5
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 5
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 1
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 4
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 17
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 1
McLean Hospital and Program in Neuroscience, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 0
Merck & Co., Inc.
Career Start Year 1989
Number of shared co-authors 1
University of North Carolina
Career Start Year 1981
Number of shared co-authors 1

Collaborators

Gladstone Institute of Virology
Co-authored papers 12
Gladstone Institutes
Co-authored papers 11
Gladstone Institutes
Co-authored papers 8
Gladstone Institutes
Co-authored papers 7
Gladstone Institutes
Co-authored papers 6
University of California San Francisco
Co-authored papers 5
Gladstone Institute of Virology
Co-authored papers 5
Gladstone Institutes
Co-authored papers 5
Gladstone Institutes
Co-authored papers 4
Co-authored papers 4
Innovative Genomics Institute, University of California berkeley
Co-authored papers 4
Gladstone Institutes
Co-authored papers 4
Gladstone Institutes
Co-authored papers 3
University of California san francisco
Co-authored papers 2
Gladstone Institute of Virology, Gladstone Institutes San Francisco CA USA .
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Synthego Corporation
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Gladstone Institute of Virology
Co-authored papers 2
University of California berkeley
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Synthego Corporation
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of CaliforniaSan Francisco
Co-authored papers 2
Center for Computational Biology, University of California berkeley
Co-authored papers 2
University of California-San Francisco
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Co-authored papers 2